# | Code | QID |
Subspecialty
|
Topic
|
Complexity
|
Importance
|
Question Count |
---|---|---|---|---|---|---|---|
1 | M1.PY.17.4698 | 108207 | Personality Disorders |
M 3
|
A
|
0
0%
0
|
|
2 | M1.OMB.20.4673 | 214219 | Chronic Kidney Disease (CKD) |
M 2
|
A
|
0
0%
0
|
|
3 | M1.BC.17.4695 | 107982 | Fat Soluble Vitamins |
M 1
|
A
|
0
0%
0
|
|
4 | M1.OMB.4874 | 214529 | Ethical Principles |
M 1
|
A
|
0
0%
0
|
|
5 | M1.OMB.4875 | 214775 | Ethical Principles |
M 1
|
A
|
0
0%
0
|
|
6 | M1.OMB.1 | 214605 | Ethical Principles |
M 1
|
A
|
0
0%
0
|
|
7 | M1.OMB.1 | 214770 | Ethical Principles |
M 1
|
A
|
0
0%
0
|
|
8 | M1.OMB.1 | 214355 | Ethical Principles |
M 3
|
A
|
0
0%
0
|
|
9 | M1.OMB.20.1 | 213740 | Ethical Principles |
M 3
|
A
|
0
0%
0
|
|
10 | M1.OMB.1 | 214645 | Legal Principles |
M 1
|
A
|
0
0%
0
|
|
11 | M1.OMB.4771 | 214774 | Legal Principles |
M 1
|
A
|
0
0%
0
|
|
12 | M1.OMB.20.4770 | 214203 | Legal Principles |
M 1
|
A
|
0
0%
0
|
|
13 | M1.OMB.1 | 214602 | Testing and Screening |
M 1
|
A
|
0
0%
0
|
|
14 | M1.OMB.20.4730 | 213799 | Testing and Screening |
A
|
0
0%
0
|
||
15 | M1.OMB.4732 | 214850 | Testing and Screening |
M 1
|
A
|
0
0%
0
|
|
16 | M1.OMB.4731 | 214561 | Testing and Screening |
M 1
|
A
|
0
0%
0
|
|
17 | M1.OMB.20.1 | 214196 | Acute Kidney Injury |
M 2
|
A
|
0
0%
0
|
|
18 | M1.CV.15.75 | 106831 | Cardiac Cycle |
M 1
|
A
|
0
0%
0
|
|
19 | M1.OMB.4886 | 214347 | Lipid Lowering Drugs |
M 3
|
A
|
0
0%
0
|
|
20 | M1.OMB.1 | 214611 | Lipid Lowering Drugs |
M 3
|
A
|
0
0%
0
|
|
21 | M1.OMB.1 | 214372 | Lipid Lowering Drugs |
M 3
|
A
|
0
0%
0
|
|
22 | M1.OMB.1 | 214959 | Lipid Lowering Drugs |
M 3
|
A
|
0
0%
0
|
|
23 | M1.OMB.4887 | 214806 | Observational Studies |
M 1
|
A
|
0
0%
0
|
|
24 | M1.OMB.1 | 214713 | Observational Studies |
M 1
|
A
|
0
0%
0
|
|
25 | M1.OMB.4885 | 214681 | Observational Studies |
M 1
|
A
|
0
0%
0
|
|
26 | M1.OMB.1 | 214777 | Observational Studies |
M 1
|
A
|
0
0%
0
|
|
27 | M1.OMB.4886 | 214746 | Observational Studies |
M 1
|
A
|
0
0%
0
|
|
28 | M1.OMB.20.4875 | 214229 | Congestive Heart Failure |
M 2
|
A
|
0
0%
0
|
|
29 | M1.OMB.20.1 | 213781 | Congestive Heart Failure |
M 3
|
A
|
0
0%
0
|
|
30 | M1.OMB.1 | 214915 | Modes of Inheritance |
M 1
|
A
|
0
0%
0
|
|
31 | M1.OMB.4876 | 214474 | Modes of Inheritance |
M 1
|
A
|
0
0%
0
|
|
32 | M1.OMB.1 | 214427 | Modes of Inheritance |
M 2
|
A
|
0
0%
0
|
|
33 | M1.OMB.20.4875 | 213879 | Modes of Inheritance |
M 1
|
A
|
0
0%
0
|
|
34 | M1.OMB.1 | 214601 | Lysosome |
M 2
|
A
|
0
0%
0
|
|
35 | M1.OMB.20.1 | 214271 | Lysosome |
M 2
|
A
|
0
0%
0
|
|
36 | M1.OMB.20.1 | 213780 | Lysosome |
M 2
|
A
|
0
0%
0
|
|
37 | M1.OMB.1 | 214914 | Myocardial Infarction |
M 1
|
A
|
0
0%
0
|
|
38 | M1.OMB.4799 | 214711 | Mycobacterium Tuberculosis |
M 1
|
A
|
0
0%
0
|
|
39 | M1.OMB.1 | 214365 | Myocardial Infarction |
M 1
|
A
|
0
0%
0
|
|
40 | M1.OMB.1 | 214613 | Mycobacterium Tuberculosis |
M 4
|
A
|
0
0%
0
|
|
41 | M1.OMB.4875 | 214454 | Myocardial Infarction |
M 2
|
A
|
0
0%
0
|
|
42 | M1.OMB.1 | 214633 | Statistical Distribution |
M 1
|
A
|
0
0%
0
|
|
43 | M1.OMB.4888 | 214925 | Statistical Distribution |
M 1
|
A
|
0
0%
0
|
|
44 | M1.ST.12.4887 | 214373 | Statistical Distribution |
M 1
|
A
|
0
0%
0
|
|
45 | M1.OMB.20.4767 | 214302 | Statistical Measures |
M 1
|
A
|
0
0%
0
|
|
46 | M1.OMB.20.1 | 214276 | Cranial Nerves |
M 2
|
A
|
0
0%
0
|
|
47 | M1.OMB.4768 | 214930 | Baroreceptors and Chemoreceptors |
M 3
|
A
|
0
0%
0
|
|
48 | M1.OMB.20.4767 | 213839 | Baroreceptors and Chemoreceptors |
M 1
|
A
|
0
0%
0
|
|
49 | M1.OMB.20.1 | 214199 | Baroreceptors and Chemoreceptors |
M 1
|
A
|
0
0%
0
|
|
50 | M1.OMB.20.1 | 214193 | Statistical Measures |
M 1
|
A
|
0
0%
0
|
|
51 | M1.OMB.4802 | 214981 | Diabetes Drugs |
M 1
|
A
|
0
0%
0
|
|
52 | M1.OMB.1 | 214773 | Diabetes Drugs |
M 3
|
A
|
0
0%
0
|
|
53 | M1.OMB.20.138 | 213869 | Emphysema |
M 2
|
A
|
0
0%
0
|
|
54 | M1.OMB.1 | 214598 | Emphysema |
M 1
|
A
|
0
0%
0
|
|
55 | M1.OMB.20.1 | 213887 | Amino Acid Catabolism |
M 1
|
A
|
0
0%
0
|
|
56 | M1.OMB.1 | 214889 | Cardiomyopathies |
M 2
|
A
|
0
0%
0
|
|
57 | M1.OMB.4868 | 214483 | Bias |
M 1
|
A
|
0
0%
0
|
|
58 | M1.OMB.1 | 214982 | Amino Acid Catabolism |
M 2
|
A
|
0
0%
0
|
|
59 | M1.OMB.20.1 | 213854 | Cardiomyopathies |
M 2
|
A
|
0
0%
0
|
|
60 | M1.OMB.4698 | 214697 | Sickle Cell Anemia |
M 1
|
A
|
0
0%
0
|
|
61 | M1.OMB.20.4801 | 213892 | Other Eating Disorders |
M 4
|
A
|
0
0%
0
|
|
62 | M1.OMB.1 | 214640 | Germ Layer Derivatives |
M 1
|
A
|
0
0%
0
|
|
63 | M1.OMB.4802 | 214797 | Other Eating Disorders |
M 2
|
A
|
0
0%
0
|
|
64 | M1.OMB.1 | 214517 | Asthma |
M 2
|
A
|
0
0%
0
|
|
65 | M1.OMB.20.4802 | 214288 | Germ Layer Derivatives |
M 2
|
A
|
0
0%
0
|
|
66 | M1.OMB.4698 | 214215 | Asthma |
M 3
|
A
|
0
0%
0
|
|
67 | M1.OMB.4803 | 214950 | Other Eating Disorders |
M 2
|
A
|
0
0%
0
|
|
68 | M1.OMB.20.1 | 214275 | Valvular Disease |
M 2
|
A
|
0
0%
0
|
|
69 | M1.OMB.4755 | 214939 | Valvular Disease |
M 2
|
A
|
0
0%
0
|
|
70 | M1.OMB.1 | 213853 | Ischemic Stroke |
M 2
|
A
|
0
0%
0
|
|
71 | M1.OMB.1 | 214362 | Poisons and Treatments |
M 2
|
A
|
0
0%
0
|
|
72 | M1.OMB.142 | 214524 | Chronic Bronchitis |
M 2
|
A
|
0
0%
0
|
|
73 | M1.OMB.4800 | 214810 | Opportunistic Mycoses |
M 2
|
A
|
0
0%
0
|
|
74 | M1.OMB.4818 | 214460 | Diabetes Mellitus |
M 2
|
A
|
0
0%
0
|
|
75 | M1.OMB.1 | 214441 | Lung Cancer |
M 2
|
A
|
0
0%
0
|
|
76 | M1.OMB.1 | 214610 | Chromosomal Diseases |
M 2
|
A
|
0
0%
0
|
|
77 | M1.OMB.20.1 | 213883 | Opiates |
M 1
|
A
|
0
0%
0
|
|
78 | M1.OMB.4800 | 214551 | Sarcoidosis |
M 1
|
A
|
0
0%
0
|
|
79 | M1.OMB.20.1 | 214278 | Primary Brain Tumors |
M 2
|
A
|
0
0%
0
|
|
80 | M1.OMB.4873 | 214330 | Drug Reactions and Side Effects |
M 2
|
A
|
0
0%
0
|
|
81 | M1.OMB.20.4758 | 214220 | Urinary Tract Infection |
M 3
|
A
|
0
0%
0
|
|
82 | M1.OMB.20.4874 | 213726 | Primary Brain Tumors |
M 2
|
A
|
0
0%
0
|
|
83 | M1.OMB.4759 | 214653 | Urinary Tract Infection |
M 3
|
A
|
0
0%
0
|
|
84 | M1.OMB.1 | 214323 | Opiates |
M 2
|
A
|
0
0%
0
|
|
85 | M1.OMB.20.1 | 213779 | Opiates |
M 3
|
A
|
0
0%
0
|
|
86 | M1.OMB.4874 | 214926 | Drug Reactions and Side Effects |
M 3
|
A
|
0
0%
0
|
|
87 | M1.OMB.20.1 | 213768 | Graves Disease |
M 2
|
A
|
0
0%
0
|
|
88 | M1.OMB.4755 | 214612 | Atrioventricular (AV) Heart Block |
M 2
|
A
|
0
0%
0
|
|
89 | M1.OMB.4771 | 214936 | Eye Movement |
M 2
|
A
|
0
0%
0
|
|
90 | M1.OMB.20.1 | 213882 | Atrioventricular (AV) Heart Block |
M 2
|
A
|
0
0%
0
|
|
91 | M1.OMB.1 | 214735 | GI Embryology |
M 2
|
A
|
0
0%
0
|
|
92 | M1.OMB.4770 | 214721 | Eye Movement |
M 2
|
A
|
0
0%
0
|
|
93 | M1.OMB.4725 | 214480 | Osteoporosis |
M 2
|
A
|
0
0%
0
|
|
94 | M1.OMB.4726 | 214893 | Osteoporosis |
M 2
|
A
|
0
0%
0
|
|
95 | M1.OMB.4885 | 213793 | Pneumoconioses |
M 2
|
A
|
0
0%
0
|
|
96 | M1.OMB.20.4868 | 213891 | Bruton Agammaglobulinemia |
M 2
|
A
|
0
0%
0
|
|
97 | M1.OMB.20.4754 | 214200 | Antianginal Therapy |
M 3
|
A
|
0
0%
0
|
|
98 | M1.OMB.20.4870 | 213798 | Nephrolithiasis |
M 2
|
A
|
0
0%
0
|
|
99 | M1.OMB.20.1 | 214273 | Fat Soluble Vitamins |
M 2
|
A
|
0
0%
0
|
|
100 | M1.OMB.20.4886 | 214299 | Pneumoconioses |
M 2
|
A
|
0
0%
0
|
|
101 | M1.OMB.1 | 214747 | Nephrolithiasis |
M 2
|
A
|
0
0%
0
|
|
102 | M1.OMB.20.4801 | 214223 | HIV |
M 2
|
A
|
0
0%
0
|
|
103 | M1.OMB.1 | 214972 | Hepatitis B Virus |
M 2
|
A
|
0
0%
0
|
|
104 | M1.OMB.1 | 214908 | Hypersensitivity |
M 1
|
A
|
0
0%
0
|
|
105 | M1.OMB.1 | 214582 | Hepatitis B Virus |
M 4
|
A
|
0
0%
0
|
|
106 | M1.OMB.1 | 214970 | DNA Repair |
M 1
|
A
|
0
0%
0
|
|
107 | M1.OMB.4871 | 214929 | Branchial Apparatus |
M 2
|
A
|
0
0%
0
|
|
108 | M1.OMB.1 | 214706 | Innate Immune Response |
M 1
|
A
|
0
0%
0
|
|
109 | M1.OMB.1 | 214351 | Innate Immune Response |
M 1
|
A
|
0
0%
0
|
|
110 | M1.OMB.96 | 214702 | Crohn Disease |
M 2
|
A
|
0
0%
0
|
|
111 | M1.OMB.4889 | 214335 | Rheumatoid Arthritis |
M 3
|
A
|
0
0%
0
|
|
112 | M1.OMB.4800 | 214328 | Treponema pallidum / Syphilis |
M 2
|
A
|
0
0%
0
|
|
113 | M1.OMB.4875 | 214556 | Renal Artery Stenosis |
M 2
|
A
|
0
0%
0
|
|
114 | M1.OMB.4801 | 214481 | Treponema pallidum / Syphilis |
M 2
|
A
|
0
0%
0
|
|
115 | M1.OMB.1 | 214358 | Renal Artery Stenosis |
M 2
|
A
|
0
0%
0
|
|
116 | M1.OMB.4890 | 214455 | Rheumatoid Arthritis |
M 2
|
A
|
0
0%
0
|
|
117 | M1.OMB.4728 | 214332 | Malignant Bone Tumors |
M 2
|
A
|
0
0%
0
|
|
118 | M1.OMB.4709 | 214374 | Coarctation of the Aorta |
M 2
|
A
|
0
0%
0
|
|
119 | M1.ST.12.3 | 214375 | Statistical Hypotheses and Error |
M 1
|
A
|
0
0%
0
|
|
120 | M1.OMB.4873 | 213875 | Neonatal Respiratory Distress Syndrome |
M 2
|
A
|
0
0%
0
|
|
121 | M1.OMB.20.4662 | 213860 | Population Genetics |
M 1
|
A
|
0
0%
0
|
|
122 | M1.OMB.4708 | 214334 | Coarctation of the Aorta |
M 2
|
A
|
0
0%
0
|
|
123 | M1.OMB.20.1 | 214180 | Anticoagulants |
M 3
|
A
|
0
0%
0
|
|
124 | M1.OMB.20.1 | 213885 | Glucose Transport |
M 1
|
A
|
0
0%
0
|
|
125 | M1.OMB.20.1 | 214279 | Obsessive-Compulsive Disorder |
M 3
|
A
|
0
0%
0
|
|
126 | M1.OMB.20.1 | 213717 | G Protein-Coupled Receptors (GPCR) |
M 1
|
A
|
0
0%
0
|
|
127 | M1.OMB.1 | 214583 | Measures of Association |
M 1
|
A
|
0
0%
0
|
|
128 | M1.OMB.4751 | 214619 | Cirrhosis and Portal Hypertension |
M 2
|
A
|
0
0%
0
|
|
129 | M1.OMB.1 | 214636 | Glucose Transport |
M 1
|
A
|
0
0%
0
|
|
130 | M1.OMB.20.1 | 213714 | Acute Interstitial Nephritis |
M 3
|
A
|
0
0%
0
|
|
131 | M1.OMB.1 | 214515 | Acid-Base Differential Diagnosis |
M 2
|
A
|
0
0%
0
|
|
132 | M1.OMB.20.4818 | 213846 | Diabetic Ketoacidosis (DKA) |
M 2
|
A
|
0
0%
0
|
|
133 | M1.OMB.1 | 214614 | Insulin and Glucagon |
M 3
|
A
|
0
0%
0
|
|
134 | M1.OMB.20.1 | 213787 | Immunosuppressive Drugs |
M 3
|
A
|
0
0%
0
|
|
135 | M1.OMB.1 | 214430 | Antibodies |
M 1
|
A
|
0
0%
0
|
|
136 | M1.OMB.4876 | 214700 | Pulmonary Hypertension |
M 2
|
A
|
0
0%
0
|
|
137 | M1.OMB.1 | 214432 | Pulmonary Hypertension |
M 3
|
A
|
0
0%
0
|
|
138 | M1.OMB.4756 | 214630 | Clostridioides difficile |
M 4
|
A
|
0
0%
0
|
|
139 | M1.OMB.4869 | 214736 | Antibodies |
M 1
|
A
|
0
0%
0
|
|
140 | M1.OMB.1 | 214968 | Asthma Drugs |
M 1
|
A
|
0
0%
0
|
|
141 | M1.OMB.4741 | 214597 | Meckel Diverticulum |
M 2
|
A
|
0
0%
0
|
|
142 | M1.OMB.20.1 | 213716 | Loop Diuretics |
M 3
|
A
|
0
0%
0
|
|
143 | M1.OMB.4818 | 214349 | CNS Infections: Protozoa |
M 2
|
A
|
0
0%
0
|
|
144 | M1.OMB.4721 | 214384 | Scaphoid Fracture |
M 4
|
A
|
0
0%
0
|
|
145 | M1.OMB.1 | 214510 | Achondroplasia |
M 2
|
A
|
0
0%
0
|
|
146 | M1.OMB.1 | 214734 | Cell-Mediated Immunity |
M 1
|
A
|
0
0%
0
|
|
147 | M1.OMB.1 | 214756 | Hypertension |
M 2
|
A
|
0
0%
0
|
|
148 | M1.OMB.1 | 214591 | RNA Processing |
M 1
|
A
|
0
0%
0
|
|
149 | M1.OMB.4701 | 214463 | B12 Deficiency |
M 2
|
A
|
0
0%
0
|
|
150 | M1.OMB.1 | 214434 | Collagen |
M 2
|
A
|
0
0%
0
|